JF
IMNM icon

Jump Financial’s Immunome IMNM Stock Holding History

Jump Financial’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$516K Buy
+23,577
New +$525K 0.01% 1227
2024
Q3 		– Sell
-134,300
Closed -$1.63M – 1861
2024
Q2 		$1.63M Buy
+134,300
New +$2.1M 0.03% 636
2024
Q1 		– Sell
-16,100
Closed -$172K – 2069
2023
Q4 		$172K Buy
+16,100
New +$134K 0.01% 1601

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Jump Financial's IMNM Position: Q1 2026 in Review

Jump Financial opened a new position in Immunome (IMNM) in Q1 2026: 23,577 shares worth $516K. The stake represents 0.01% of the portfolio and ranks #1227 among its holdings. This is a return to the name: Jump Financial previously reported a position in IMNM as recently as Q2 2024.

Jump Financial first reported a position in IMNM in Q4 2023 and has held it in 3 quarters since. The position peaked at $1.63M in Q2 2024. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Jump Financial held 23,577 shares of Immunome worth $516K as of Q1 2026.
  • Immunome was a new Jump Financial position in Q1 2026.
  • Immunome made up 0.01% of Jump Financial's portfolio in Q1 2026, its #1227 holding.
  • Jump Financial first reported a position in Immunome in Q4 2023 and has held it in 3 quarters since.
  • Jump Financial's Immunome position peaked at $1.63M in Q2 2024.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.